NAGE short interest
Niagen Bioscience Inc · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 3,874,102 |
|---|---|
| Change vs prior report | -122,216 (-3.1%) |
| Change over six months | -29.5% |
| Days to cover | 9.86 (sector: 3.78) |
| Average daily volume | 392,984 |
| Rank in Healthcare | #115 of 922 by days to cover |
NAGE short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 3,874,102 | -3.1% | 9.86 | 392,984 |
| 2026-09-15 | 3,996,318 | -3.8% | 11.29 | 353,835 |
| 2026-08-31 | 4,155,915 | -3.6% | 8.83 | 470,620 |
| 2026-08-14 | 4,312,635 | -5.1% | 5.36 | 805,085 |
| 2026-07-31 | 4,545,665 | -5.0% | 7.24 | 627,510 |
| 2026-07-15 | 4,786,324 | +8.9% | 6.53 | 733,057 |
| 2026-06-30 | 4,394,606 | -2.3% | 5.57 | 789,556 |
| 2026-06-15 | 4,498,798 | -4.6% | 6.90 | 652,114 |
| 2026-05-29 | 4,715,950 | -5.5% | 4.75 | 993,553 |
| 2026-05-15 | 4,990,181 | -7.6% | 3.95 | 1,262,895 |
| 2026-04-30 | 5,401,652 | -0.9% | 7.95 | 679,304 |
| 2026-04-15 | 5,453,364 | -0.8% | 9.12 | 598,108 |
| 2026-03-31 | 5,496,661 | -1.5% | 4.45 | 1,235,190 |
| 2026-03-13 | 5,578,868 | -13.6% | 2.20 | 2,530,386 |
| 2026-02-27 | 6,457,826 | -0.6% | 7.16 | 901,453 |
| 2026-02-13 | 6,494,766 | +9.4% | 7.18 | 905,098 |
| 2026-01-30 | 5,935,773 | +2.3% | 8.27 | 717,533 |
| 2026-01-15 | 5,801,384 | +2.2% | 6.52 | 889,352 |
| 2025-12-31 | 5,674,234 | +1.5% | 7.09 | 799,911 |
| 2025-12-15 | 5,589,502 | +1.2% | 7.63 | 732,195 |
| 2025-11-28 | 5,521,464 | -2.0% | 7.03 | 784,881 |
| 2025-11-14 | 5,634,298 | +11.0% | 4.69 | 1,200,868 |
| 2025-10-31 | 5,076,831 | +21.7% | 5.63 | 901,448 |
| 2025-10-15 | 4,172,117 | +11.2% | 2.72 | 1,532,065 |
| 2025-09-30 | 3,751,819 | -4.8% | 3.86 | 973,007 |
import finzdata as yf
yf.Ticker("NAGE").short_interest # every report since 2017
yf.Client().short_interest(["NAGE"], start="2018-01-01")Healthcare short interest · NAGE price history · Who owns NAGE · All short interest